Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Energy Vault
NRGV
$651M
| $7.15M | ﹤0.01% |
722,187
+247,874
| +52% | +$2.41M |
|
|
CBAY
2427
DELISTED
Cymabay Therapeutics
CBAY
| $7.15M | ﹤0.01% |
1,958,653
-144,159
| -7% | -$568K |
|
2428
BioLife Solutions
BLFS
$1.78B
| $7.15M | ﹤0.01% |
168,881
-491,755
| -74% | -$23.7M |
|
2429
CALL
Airbnb
ABNB
$112B
| $7.15M | ﹤0.01% |
42,600
+40,200
| +1,675% | +$6.14M |
|
2430
CALL
Chegg
CHGG
$94M
| $7.14M | ﹤0.01% |
105,000
-11,300
| -10% | -$920K |
|
2431
PUT
Monster Beverage
MNST
$91.9B
| $7.14M | ﹤0.01% |
321,600
-37,600
| -10% | -$889K |
|
2432
Primoris Services
PRIM
$3.95B
| $7.14M | ﹤0.01% |
291,534
-29,349
| -9% | -$789K |
|
2433
Rogers Corp
ROG
$2.24B
| $7.14M | ﹤0.01% |
38,278
+10,150
| +36% | +$2M |
|
2434
Vaxcyte
PCVX
$8.92B
| $7.14M | ﹤0.01% |
281,284
-34,329
| -11% | -$832K |
|
|
FVT
2435
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $7.13M | ﹤0.01% |
731,381
-287,726
| -28% | -$2.81M |
|
2436
Golar LNG
GLNG
$5.15B
| $7.12M | ﹤0.01% |
548,846
-1,911,603
| -78% | -$22.1M |
|
2437
Q2 Holdings
QTWO
$4.07B
| $7.12M | ﹤0.01% |
88,802
+66,995
| +307% | +$6.14M |
|
|
PDCE
2438
DELISTED
PDC Energy, Inc.
PDCE
| $7.11M | ﹤0.01% |
150,003
-417,714
| -74% | -$17.4M |
|
|
FLYA.U
2439
DELISTED
SOAR Technology Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
FLYA.U
| $7.11M | ﹤0.01% |
+700,000
| New | +$7.12M |
|
2440
CALL
Healthcare Realty
HR
$6.52B
| $7.1M | ﹤0.01% |
+239,400
| New | +$6.98M |
|
2441
Better Home & Finance Holding
BETR
$267M
| $7.1M | ﹤0.01% |
14,299
-5,235
| -27% | -$2.6M |
|
2442
Nurix Therapeutics
NRIX
$2.73B
| $7.1M | ﹤0.01% |
236,883
-189,103
| -44% | -$5.84M |
|
2443
Organogenesis Holdings
ORGO
$221M
| $7.06M | ﹤0.01% |
495,863
-494,584
| -50% | -$7.68M |
|
2444
ZTO Express
ZTO
$16.4B
| $7.06M | ﹤0.01% |
230,229
-1,402,630
| -86% | -$40.2M |
|
|
SIVB
2445
DELISTED
SVB Financial Group
SIVB
| $7.05M | ﹤0.01% |
10,904
-43,106
| -80% | -$25M |
|
2446
A.O. Smith
AOS
$8.22B
| $7.05M | ﹤0.01% |
115,483
+103,611
| +873% | +$7.24M |
|
|
CERN
2447
CALL
DELISTED
Cerner Corp
CERN
| $7.05M | ﹤0.01% |
100,000
-120,000
| -55% | -$9.27M |
|
2448
Hope Bancorp
HOPE
$1.78B
| $7.05M | ﹤0.01% |
488,221
+17,685
| +4% | +$241K |
|
|
2449
Chegg
CHGG
$94M
| $7.04M | ﹤0.01% |
103,534
+78,991
| +322% | +$6.43M |
|
2450
Beyond Meat
BYND
$239M
| $7.03M | ﹤0.01% |
2,226
+1,298
| +140% | +$4.76M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.